Should Biogen Buy Alkermes? Post author:Sam Post published:February 27, 2018 Post category:BioPharma After a huge dry spell in M&A, 2018 is shaping up to be a great year for deal making. Source: BioSpace You Might Also Like Embattled Marathon Pharma May Shutter Operations by May 1 April 24, 2017 Court Sets the Trial Date For MiMedx Patent Infringement Lawsuit Against MTF, Medline And Liventa October 1, 2017 Cambridge Biotech Obsidian Launches With $49.5M Investment From Google, Takeda, Vertex, Amgen and… December 5, 2017
Court Sets the Trial Date For MiMedx Patent Infringement Lawsuit Against MTF, Medline And Liventa October 1, 2017
Cambridge Biotech Obsidian Launches With $49.5M Investment From Google, Takeda, Vertex, Amgen and… December 5, 2017
